A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder
E Vieta, S Montgomery, AH Sulaiman… - European …, 2012 - Elsevier
The efficacy and safety of risperidone long-acting injectable (LAI) for preventing recurrence
of mood episodes in patients with bipolar I disorder was evaluated in a randomized, placebo …
of mood episodes in patients with bipolar I disorder was evaluated in a randomized, placebo …
A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder
E Vieta, S Montgomery, A Hatim Sulaiman, B Huberlant… - 2012 - lareferencia.info
The efficacy and safety of risperidone long-acting injectable (LAI) for preventing recurrence
of mood episodes in patients with bipolar I disorder was evaluated in a randomized, placebo …
of mood episodes in patients with bipolar I disorder was evaluated in a randomized, placebo …
A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder
E Vieta, S Montgomery, AH Sulaiman… - European …, 2012 - pure.urosario.edu.co
The efficacy and safety of risperidone long-acting injectable (LAI) for preventing recurrence
of mood episodes in patients with bipolar I disorder was evaluated in a randomized, placebo …
of mood episodes in patients with bipolar I disorder was evaluated in a randomized, placebo …
A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder
E Vieta, S Montgomery, AH Sulaiman… - European …, 2012 - infona.pl
The efficacy and safety of risperidone long-acting injectable (LAI) for preventing recurrence
of mood episodes in patients with bipolar I disorder was evaluated in a randomized, placebo …
of mood episodes in patients with bipolar I disorder was evaluated in a randomized, placebo …
A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder
E Vieta, S Montgomery, AH Sulaiman, R Cordoba… - 2012 - pubmed.ncbi.nlm.nih.gov
The efficacy and safety of risperidone long-acting injectable (LAI) for preventing recurrence
of mood episodes in patients with bipolar I disorder was evaluated in a randomized, placebo …
of mood episodes in patients with bipolar I disorder was evaluated in a randomized, placebo …
A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder
E Vieta, S Montgomery, AH Sulaiman… - European …, 2012 - eprints.um.edu.my
The efficacy and safety of risperidone long acting injectable (LAI) for preventing recurrence
of mood episodes in patient with bipolar| disorder was evaluated in a randomized …
of mood episodes in patient with bipolar| disorder was evaluated in a randomized …
A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder.
E Vieta, S Montgomery, AH Sulaiman… - … : the Journal of the …, 2012 - europepmc.org
The efficacy and safety of risperidone long-acting injectable (LAI) for preventing recurrence
of mood episodes in patients with bipolar I disorder was evaluated in a randomized, placebo …
of mood episodes in patients with bipolar I disorder was evaluated in a randomized, placebo …
A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder
E Vieta, S Montgomery, A Hatim Sulaiman… - 2012 - repository.urosario.edu.co
The efficacy and safety of risperidone long-acting injectable (LAI) for preventing recurrence
of mood episodes in patients with bipolar I disorder was evaluated in a randomized, placebo …
of mood episodes in patients with bipolar I disorder was evaluated in a randomized, placebo …
[引用][C] A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I …
E Vieta, S Montgomery, AH Sulaiman… - European …, 2012 - cir.nii.ac.jp
A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes
with risperidone long-acting injectable in patients with bipolar I disorder | CiNii Research CiNii …
with risperidone long-acting injectable in patients with bipolar I disorder | CiNii Research CiNii …
A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder
E Vieta, S Montgomery, AH Sulaiman… - European …, 2012 - pure.urosario.edu.co
The efficacy and safety of risperidone long-acting injectable (LAI) for preventing recurrence
of mood episodes in patients with bipolar I disorder was evaluated in a randomized, placebo …
of mood episodes in patients with bipolar I disorder was evaluated in a randomized, placebo …